EOAI3402143

EOAI3402143 is an inhibitor of DUB used in studies of Apoptosis and Protein Degradation / Proteasome. In practice, this places the compound in experiments that measure caspase-associated cell-death signaling and survival decisions and ubiquitin-dependent turnover, proteostasis, and targeted protein degradation in apoptosis, cancer, and protein homeostasis models.

By inhibiting DUB, EOAI3402143 can be used to examine caspase-associated cell-death signaling and survival decisions and ubiquitin-dependent turnover, proteostasis, and targeted protein degradation. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and protein homeostasis models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving DUB
• Pathway perturbation studies connected to Apoptosis and Protein Degradation / Proteasome
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, EOAI3402143 is appropriate when a defined chemical perturbant is needed to connect DUB with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and protein homeostasis models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.